Communicable Disease Investigation Reference Manual

Table of Contents

1.0  Introduction

(Revised 8/13)

2.0  Map - Districts for Statewide Disease Investigation/Terrorism Response/TB Control

(Updated 3/15)

3.0  Communicable Disease Surveillance

(Updated 12/14)

4.0  Diseases or Conditions



    Animal Bites / Injuries



(Revised 2/11)

    Arboviral Diseases, Neuroinvasive and Non-Neuroinvasive

(New 4/15)

        California Serogroup Viruses, including La Crosse Virus

        Chikungunya Virus

        Eastern Equine Encephalitis Virus

        Powassan Virus

        St. Louis Encephalitis Virus

        Venezuelan Equine Encephalitis Virus

        West Nile

        Western Equine Encephalitis


(Revised 12/13)


(Revised 10/13)


(Revised 3/15)



    Chlamydia Trachomatis



(Updated 4/12)


(Revised 1/12)

    Creutzfeldt-Jakob Disease

(Revised 5/05)


(Revised 8/11)


(Revised 10/11)


(Revised 1/15)


(Updated 3/12)

    Escherichia coli O157:H7/Other Hemorrhagic E. coli

(Revised 6/11)


(Revised 4/08)


(Revised 2/14)


(Updated 3/12)



    Haemophilus influenzae, Invasive

(Revised 1/15)

    Hansen's Disease (Leprosy)

(Revised 4/12)

    Hantavirus Infections

(Revised 6/15)

    Hemolytic Uremic Syndrome (HUS), post-diarrheal

(Revised 6/11)

    Hemorrhagic Fevers (Viral)

(Revised 8/14)

         Arenaviridae: South American Hemorrhagic Viral Fevers (New World Arenaviruses)

         Arenaviridae: Lassa Fever (Old World Arenavirus)

         Bunyaviridae: Crimean-Congo Hemorrhagic Fever

         Filoviridae: Ebola Hemorrhagic Fever

         Filoviridae: Marburg Hemorrhagic Fever

    Hepatitis A

(Revised 11/13)

    Hepatitis B, acute/Delta Hepatitis

(Revised 7/08)

    Hepatitis C

(Revised 6/08)




(Updated 9/09)

    Latent Tuberculosis Infection

(Revised 3/14)


(Revised 12/13)


(Updated 11/15)


(Updated 1/14)

    Lyme-like Disease

(Revised 5/08)


(Revised 3/14)


(Updated 8/13)

    Meningococcal Disease

(Revised 1/15)

    Methicillin–resistant Staphylococcus aureus (MRSA)



(Revised 8/13)

    Nontuberculous Mycobacterium (NTM) / MOTT

(Revised 1/15)

    Outbreak Investigation

(Revised 7/14)

    Other Sexually Transmitted Diseases


          Nongonococcal Urethritis

          Mucopurulent Cervicitis

          Bacterial Vaginosis

          Trichomonal Vaginosis

          Vulvovaginal Candidiasis

          Genital Herpes

          Lymphogranuloma Venereum

          Molluscum Contagiousum

          Pelvic Inflammatory Disease (PID)

          Urinary Tract Infection

          Human Papillomavirus

          Acute Epididymitis




(Revised 3/14)


(Revised 9/12)


(Updated 5/12)


(Updated 3/05)

    Q fever

(Revised 5/15)



          Rabies, animal

(Revised 1/14)

          Rabies, human

(Revised 1/14)


(Updated 2/13)

    Rocky Mountain Spotted Fever

(Revised 4/08)


(Revised 11/13)

    Salmonellosis, Nontyphoidal (NTS)

(Revised 8/15)

    Shiga toxin-producing E. coli (STEC) and
    Shiga toxin positive, unknown organism

(Revised 6/11)


(Revised 7/15)


(Revised 11/13)

    Streptococcus Disease

        Streptococcus Disease, invasive, Group A

(Revised 6/02)

        Streptococcus pneumoniae, drug-resistant invasive disease

(Revised 12/12)

        Streptococcus pneumoniae, invasive in children <5 years  

(Revised 12/12)

        Streptococcal Toxic Shock Syndrome

(Revised 6/00)



    T-2 Mycotoxins



(Revised 11/13)

    Toxic Shock Syndrome

(Revised 6/02)


(Revised 4/15)

    Tuberculosis Disease

(Revised 3/12)


(Revised 4/09)

    Typhoid & Paratyphoid Fever

(Revised 7/15)

    Vaccinia, Adverse Reactions

(Revised 4/05)

    Vancomycin-Intermediate Staphylococcus aureus (VISA) and     Vancomycin-Resistant Staphylococcus aureus (VRSA)


    Varicella (Chickenpox)

(Revised 5/11)

    Vibriosis (non-cholera Vibrio species infections)


    Yellow Fever

(Updated 10/15)


(Revised 3/12)


(Revised 9/10)



Recently added manual section.


Section content is current.


Section content:  may include reporting guidelines, forms, and intervention recommendations.


Web links, agency names and phone numbers.